Obesity Medicine
Obesity medication is the field of pharmaceutical devoted to the far-reaching consideration of patients with obese. It is the field of medicine committed to the absolute care of patients with obesity. Obesity Medicine target on health and disease, relating to the very broad spectrum of research in and strike on humans.Obesity medicine clinicians who are individuals from the Obesity Medicine Association use an exhaustive, logical, and individualized approach involved nutrition, physical activity, conduct treatment, and prescription to enable patients to get more fit and accomplish better general health.
- Contrave (naltrexone HCl and bupropion HCl) ; Takeda Pharmaceuticals U.S.A.; For chronic weight management , Approved September 2014
- Jardiance (empagliflozin) ; Boehringer Ingelheim; For the treatment of type II diabetes, Approved August 2014
- Saxenda (liraglutide [rDNA origin] injection); Novo Nordisk; For chronic weight management, Approved December 2014
- Tanzeum (albiglutide); GlaxoSmithKline; For the treatment of type II diabetes mellitus, Approved April 2014
- Trulicity (dulaglutide); Eli Lilly; To improve glycemic control in type II diabetics, Approved September 2014
- Nesina (alogliptin); Takeda; For the treatment of type II diabetes mellitus, Approved January 2013
- Belviq (lorcaserin hydrochloride); Arena Pharmaceuticals; For the chronic management of weight loss, Approved June 2012
- Bydureon (exenatide extended-release for injectable suspension); Amylin; For the improvement of glycemic control in adults with type II diabetes mellitus, Approved January 2012
- Qsymia (phentermine + topiramate extended-release); Vivus; For the treatment of chronic weight management, Approved July 2012
Related Conference of Obesity Medicine
November 26-27, 2026
24th International Conference on Obesity, Diet Management & Nutrition
London, UK
Obesity Medicine Conference Speakers
Recommended Sessions
- Animal & Plant Nutrition
- Childhood Obesity
- Clinical Nutrition
- Dietary Supplements
- Genetic Obesity
- Health risks associated with obesity
- Nutrition & Food science
- Nutrition & Healthy Lifestyle
- Nutrition & Metabolism
- Nutrition & Public Health
- Nutritional Disorders
- Nutritional Epidemiology
- Nutritional Science
- Nutritional Therapy & Treatments
- Nutritional Value & Quality of foods
- Obesity & Cancer
- Obesity & Chronic Diseases
- Obesity & Diabetes
- Obesity & Endocrinology
- Obesity & Pharmacology
- Obesity & Public Health
- Obesity & Weight Management
- Obesity in Women
- Obesity Medicine
- Sports Nutrition
- Treatment of obesity
Related Journals
Are you interested in
- Advanced Treatment for Obesity - OBESITY MEDICINE 2026 (Netherlands)
- Advances in Obesity Pathophysiology - Obesity_2026 (UK)
- Anti-Obesity Drugs - OBESITY MEDICINE 2026 (Netherlands)
- Anti-Obesity Pharmacotherapy - Obesity_2026 (UK)
- Bariatric Surgery - OBESITY MEDICINE 2026 (Netherlands)
- Bariatric Surgery & Post-Operative Care - Obesity_2026 (UK)
- Bariatric Surgery: Advances and Outcomes - Obesity-2026 (UK)
- Cardiovascular Complications of Obesity - Obesity_2026 (UK)
- Childhood and Adolescent Obesity - Obesity-2026 (UK)
- Childhood and Adolescent Obesity - Obesity_2026 (UK)
- Childhood Obesity and Nutrition - OBESITY MEDICINE 2026 (Netherlands)
- Childhood Obesity Risk Factors - Childhood Obesity 2026 (France)
- Clinical Nutrition and Evidence-Based Dietetics - Obesity-2026 (UK)
- Clinical Obesity - OBESITY MEDICINE 2026 (Netherlands)
- Current Research on Obesity - OBESITY MEDICINE 2026 (Netherlands)
- Diabetes, Endocrinology and Obesity - OBESITY MEDICINE 2026 (Netherlands)
- Diabetes, Obesity, and Endocrine Health - Obesity-2026 (UK)
- Diet & Nutrition - OBESITY MEDICINE 2026 (Netherlands)
- Diet Management for Weight Loss and Long-Term Health - Obesity-2026 (UK)
- Dietary and Lifestyle Changes - OBESITY MEDICINE 2026 (Netherlands)
- Digital Health, Wearables & AI in Obesity Management - Obesity_2026 (UK)
- Digital Tools for Childhood Wellness - Childhood Obesity 2026 (France)
- Early-Life Nutrition & Growth - Childhood Obesity 2026 (France)
- Endocrine Disorders & Hormonal Imbalance - Obesity_2026 (UK)
- Family & Community Nutrition Strategies - Childhood Obesity 2026 (France)
- Food Environment & Behavioral Choices - Childhood Obesity 2026 (France)
- Food Industry, Marketing & Consumer Behavior - Obesity_2026 (UK)
- Functional Foods, Nutraceuticals, and Dietary Supplements - Obesity-2026 (UK)
- Genetics and Epigenetics of Obesity - OBESITY MEDICINE 2026 (Netherlands)
- Genetics, Epigenetics & Obesity Risk - Obesity_2026 (UK)
- Global Trends in Childhood Nutrition - Childhood Obesity 2026 (France)
- Gut Microbiome & Metabolic Health - Obesity_2026 (UK)
- Gut Microbiome, Nutrition, and Metabolic Health - Obesity-2026 (UK)
- Gynaecology & Obstetrics - OBESITY MEDICINE 2026 (Netherlands)
- Healthy Dietary Patterns in Children - Childhood Obesity 2026 (France)
- Innovations in Pediatric Dietetics - Childhood Obesity 2026 (France)
- Lifestyle Modifications & Behavioral Therapy - Obesity_2026 (UK)
- Liposuction and Weight Loss Treatments - OBESITY MEDICINE 2026 (Netherlands)
- Medical Nutrition Therapy for Chronic Diseases - Obesity-2026 (UK)
- Metabolic Syndrome and Obesity-Related Disorders - Obesity-2026 (UK)
- Micronutrient Needs in Childhood - Childhood Obesity 2026 (France)
- Non-Surgical Treatment for Obesity - OBESITY MEDICINE 2026 (Netherlands)
- Nutrigenomics and Nutrigenetics - Obesity-2026 (UK)
- Nutrition, Dietetics & Weight Management - Obesity_2026 (UK)
- Nutritional Interventions for Obesity - Childhood Obesity 2026 (France)
- Obesity & Associated Health Disorders - OBESITY MEDICINE 2026 (Netherlands)
- Obesity & Cancer - OBESITY MEDICINE 2026 (Netherlands)
- Obesity & Cardiometabolic Syndrome - Obesity_2026 (UK)
- Obesity & Liver Disorders (NAFLD/NASH) - Obesity_2026 (UK)
- Obesity and Cancer Risk - Obesity_2026 (UK)
- Obesity and Cardiovascular Diseases - OBESITY MEDICINE 2026 (Netherlands)
- Obesity and Chronic Diseases - OBESITY MEDICINE 2026 (Netherlands)
- Obesity and Diabetes Interlink - Obesity_2026 (UK)
- Obesity and Eating Disorders - OBESITY MEDICINE 2026 (Netherlands)
- Obesity and Mental Health - Obesity_2026 (UK)
- Obesity and Metabolic Diseases - OBESITY MEDICINE 2026 (Netherlands)
- Obesity and Weight Loss - OBESITY MEDICINE 2026 (Netherlands)
- Obesity and Weight Management - OBESITY MEDICINE 2026 (Netherlands)
- Obesity Causes - OBESITY MEDICINE 2026 (Netherlands)
- Obesity in Aging Populations - Obesity_2026 (UK)
- Obesity in Women - OBESITY MEDICINE 2026 (Netherlands)
- Obesity in Women’s Health - Obesity_2026 (UK)
- Obesity Prevention - OBESITY MEDICINE 2026 (Netherlands)
- Obesity: Global Trends, Prevention, and Public Health - Obesity-2026 (UK)
- Pediatric Gut Health & Nutrition - Childhood Obesity 2026 (France)
- Pediatric Metabolic Health - Childhood Obesity 2026 (France)
- Personalized Nutrition and Precision Dietetics - Obesity-2026 (UK)
- Physical Activity & Lifestyle Behaviors - Childhood Obesity 2026 (France)
- Physical Activity, Exercise & Fitness Science - Obesity_2026 (UK)
- Physical Activity, Exercise & Kinesiology - OBESITY MEDICINE 2026 (Netherlands)
- Policy Approaches to Childhood Obesity - Childhood Obesity 2026 (France)
- Public Health Strategies & Community Interventions - Obesity_2026 (UK)
- Role of Steroids and Hormones in Obesity - OBESITY MEDICINE 2026 (Netherlands)
- School-Based Nutrition Programs - Childhood Obesity 2026 (France)
- Yoga and Naturopathy - OBESITY MEDICINE 2026 (Netherlands)